AKR1C3 in carcinomas: from multifaceted roles to therapeutic strategies
Aldo-Keto Reductase Family 1 Member C3 (AKR1C3), also known as type 5 17β-hydroxysteroid dehydrogenase (17β-HSD5) or prostaglandin F (PGF) synthase, functions as a pivotal enzyme in androgen biosynthesis. It catalyzes the conversion of weak androgens, estrone (a weak estrogen), and PGD2 into potent...
Saved in:
Main Authors: | Mengnan Li (Author), Limin Zhang (Author), Jiahui Yu (Author), Xiaoxiao Wang (Author), Le Cheng (Author), Zhaowu Ma (Author), Xiaoguang Chen (Author), Lingzhi Wang (Author), Boon Cher Goh (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2024-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Unleashing the efficacy of immune checkpoint inhibitors for advanced hepatocellular carcinoma: factors, strategies, and ongoing trials
by: Jiahui Yu, et al.
Published: (2023) -
Repurposing Artemisinin and its Derivatives as Anticancer Drugs: A Chance or Challenge?
by: Zhaowu Ma, et al.
Published: (2021) -
Extracellular vesicles in the HCC microenvironment: Implications for therapy and biomarkers
by: Le Cheng, et al.
Published: (2024) -
Clinical translation of patient-derived tumour organoids- bottlenecks and strategies
by: Malia Alexandra Foo, et al.
Published: (2022) -
A Review on Liquid Chromatography-Tandem Mass Spectrometry Methods for Rapid Quantification of Oncology Drugs
by: Andrea Li-Ann Wong, et al.
Published: (2018)